Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00196066|
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : February 1, 2012
|Condition or disease||Intervention/treatment||Phase|
|Peripheral Arterial Disease (PAD)||Device: Peripheral Vessel Stenting||Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||150 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Study Start Date :||October 2002|
|Study Completion Date :||April 2006|
- The primary endpoint of the study is major adverse event (MAE) rate at the 9-month follow-up.
- Additional endpoints include acute procedure and hemodynamic success, secondary patency, 9-month restenosis rate based on ultrasound examination, and 9-month functional status improvement.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00196066
|Principal Investigator:||Gerald Zemel, MD||Baptist Cardiac and Vascular Institute|